Lantheus to Present at March 2026 Investor Conferences

Rhea-AI Summary

Lantheus (NASDAQ: LNTH) announced that Mary Anne Heino, Executive Chairperson and CEO, will present at two investor conferences in March 2026: TD Cowen 46th Annual Health Care Conference on March 3, 2026 at 11:10 a.m. ET and Leerink Global Healthcare Conference on March 10, 2026 at 8:00 a.m. ET.

Live webcasts will be accessible via the Investors section of the company's website, with replays available for at least 30 days following each presentation.

News Market Reaction – LNTH

+0.26%

1 alert

+0.26% News Effect

On the day this news was published, LNTH gained 0.26%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

TD Cowen conference date: March 3, 2026 TD Cowen presentation time: 11:10 a.m. ET Leerink conference date: March 10, 2026 +2 more

5 metrics

TD Cowen conference date March 3, 2026 TD Cowen 46th Annual Health Care Conference presentation

TD Cowen presentation time 11:10 a.m. ET Scheduled time for LNTH presentation

Leerink conference date March 10, 2026 Leerink Global Healthcare Conference presentation

Leerink presentation time 8:00 a.m. ET Scheduled time for LNTH presentation

Webcast replay period at least 30 days Replay availability on company’s website

Market Reality Check

Price: $73.61 Vol: Volume 649,922 is below t...

normal vol

$73.61 Last Close

Volume Volume 649,922 is below the 20-day average of 744,436 (relative volume 0.87x). normal

Technical Price $73.42 is trading above the 200-day MA at $65.08 and 34.03% below the 52-week high.

Peers on Argus

LNTH slipped 0.61% while peers were mixed: ALKS +1.74%, PBH +0.35%, HCM +0.20%, ...

1 Down

LNTH slipped 0.61% while peers were mixed: ALKS +1.74%, PBH +0.35%, HCM +0.20%, and AMRX -0.89%, INDV -2.69%. Momentum scanner only flagged KNSA moving down, suggesting stock-specific trading rather than a coordinated sector move.

Common Catalyst Both LNTH and peer INDV reported participation in upcoming investor conferences, indicating a shared focus on investor outreach events.

Historical Context

5 past events · Latest: Feb 12 (Neutral)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Feb 12	Earnings call notice	Neutral	+2.1%	Scheduled Q4 and full-year 2025 earnings call and webcast announcement.
Jan 02	Business divestiture	Positive	+1.1%	Completed sale of SPECT business to refocus on PET and radiopharmaceuticals.
Nov 24	Clinical data presentation	Positive	+1.2%	Announced florbetaben F 18 data presentation at CTAD 2025 conference.
Nov 06	Earnings & guidance	Mixed	-6.2%	Reported Q3 2025 results, updated guidance, and multiple PDUFA dates.
Nov 06	Leadership transition	Mixed	-6.2%	Announced CEO retirement, interim leadership, and broader executive changes.

Pattern Detected

Recent LNTH news has often coincided with modest positive moves for routine updates, while the November 2025 earnings and leadership transition releases saw notably negative reactions.

Recent Company History

Over the last few months, LNTH has reported several milestones: an upcoming Feb 26, 2026 earnings call, completion of the SPECT business sale on Jan 2, 2026, and new florbetaben F 18 data at CTAD 2025. Earlier, Q3 2025 results and a leadership transition on Nov 6, 2025 were followed by a -6.19% move, contrasting with the generally positive reactions (+1.08% to +2.14%) to conference and data announcements. Today’s conference-participation news fits this pattern of ongoing investor and scientific engagement.

Market Pulse Summary

This announcement highlights LNTH’s upcoming presentations at two March 2026 healthcare investor con...

Analysis

This announcement highlights LNTH’s upcoming presentations at two March 2026 healthcare investor conferences, reinforcing ongoing engagement with the financial community. In recent months, the company has executed a SPECT divestiture, reported Q3 2025 results with updated guidance, and navigated a leadership transition. Investors may watch how messages delivered at these conferences build on prior earnings, transaction activity, and pipeline milestones disclosed in earlier releases.

AI-generated analysis. Not financial advice.

BEDFORD, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company dedicated to helping clinicians Find, Fight, and Follow disease to deliver better patient outcomes, today announced Mary Anne Heino, Executive Chairperson and Chief Executive Officer, will present at the following investor conferences.

• TD Cowen 46th Annual Health Care Conference
  March 3, 2026 at 11:10 a.m. ET
  
  
• Leerink Global Healthcare Conference
  March 10, 2026 at 8:00 a.m. ET
  

To access the live webcast of the presentations, please visit the Investors section of the Company’s website at www.lantheus.com. A replay of the webcasts will be available on the Company’s website for at least 30 days following the live presentation.

About Lantheus

Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in New Jersey, Canada, Germany, Sweden, Switzerland, and the United Kingdom, Lantheus has been providing radiopharmaceutical solutions for 70 years. For more information, visit www.lantheus.com.

Contacts:

Mark Kinarney
Vice President, Investor Relations
978-671-8842
ir@lantheus.com

Melissa Downs
Executive Director, External Communications
646-975-2533
media@lantheus.com

FAQ

When will Mary Anne Heino present for Lantheus (NASDAQ: LNTH) at the TD Cowen conference?

She will present on March 3, 2026 at 11:10 a.m. ET. According to Lantheus, the session is part of the TD Cowen 46th Annual Health Care Conference and will be available via a live webcast on the company's Investors website with a replay afterward.

What time is the Lantheus (LNTH) presentation at the Leerink Global Healthcare Conference on March 10, 2026?

The presentation is scheduled for March 10, 2026 at 8:00 a.m. ET. According to Lantheus, Mary Anne Heino will present and investors can access a live webcast through the company's Investors website, with a replay available for a limited period.

How can investors watch the Lantheus (LNTH) investor presentations in March 2026?

Investors can watch via the live webcast on the company's Investors website. According to Lantheus, both conference presentations will be streamed live and a replay will be posted on the website for at least 30 days after each live presentation.

Will Lantheus (LNTH) provide replays of the March 2026 investor presentations and for how long?

Yes, replays will be available for at least 30 days following each live presentation. According to Lantheus, webcast replays of the March 3 and March 10 presentations will be posted in the Investors section of the company website for investor access.

Who will represent Lantheus (LNTH) at the March 2026 investor conferences?

Mary Anne Heino, Executive Chairperson and CEO, will represent the company at both events. According to Lantheus, Heino will present at TD Cowen on March 3 and at Leerink on March 10, with both presentations available via webcast for investors.

Where on Lantheus (LNTH) website can I find the March 2026 presentation webcasts?

Webcasts will be located in the Investors section of the company website. According to Lantheus, live streaming links for the March 3 and March 10 presentations and subsequent replays will be posted under the Investors area at www.lantheus.com.